Drug Discovery
Wistar team cracks glioblastoma defenses with two-pronged immune attack
Wistar Institute researchers have shown that rewiring myeloid cells and activating T cells together can sharply extend survival in glioblastoma models, breaking through a cancer long known for resisting treatment.
